Filter Results :

Your search for Lymphoma returned 117 reports

Sort by


Global Non-Hodgkin Lymphoma Partnering 2010 to 2016

01 Sep 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals list...

$ 1,495.00

Read More

Global Lymphoma Partnering 2010 to 2016

01 Sep 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals list...

$ 1,495.00

Read More

Mantle Cell Lymphoma - Pipeline Review, H2 2016

10 Aug 2016  |  Published by:  Global Markets Direct
Summary'Mantle Cell Lymphoma - Pipeline Review, H2 2016', provides an overview of the Mantle Cell Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Mantle Cell Lymphoma, complete with analysis by stage of development, drug target, me...

$ 2,000.00

Read More

Indolent Lymphoma - Pipeline Review, H2 2016

10 Aug 2016  |  Published by:  Global Markets Direct
Summary'Indolent Lymphoma - Pipeline Review, H2 2016', provides an overview of the Indolent Lymphoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Indolent Lymphoma, complete with analysis by stage of development, drug target, mechanism o...

$ 2,000.00

Read More

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016

10 Aug 2016  |  Published by:  Global Markets Direct
Summary'Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) - Pipeline Review, H2 2016', provides an overview of the Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma...

$ 2,000.00

Read More

Small lymphocytic lymphoma- Market Insights, Epidemiology and Market Forecast-2023

01 Aug 2016  |  Published by:  DelveInsight
Note*: This report requires 7-10 business days to complete.DelveInsights Small lymphocytic lymphoma - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (Fran...

$ 4,950.00

Read More

Anaplastic Lymphoma Kinase (ALK) Inhibitors -Pipeline Insights, 2016

01 Aug 2016  |  Published by:  DelveInsight
SummaryDelveInsights, Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights, 2016, report provides in depth insights on the pipeline drugs and their development activities around the Anaplastic Lymphoma Kinase (ALK) Inhibitors. The DelveInsights Report covers the product profiles in various ...

$ 1,250.00

Read More

Hodgkin's lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023

01 Aug 2016  |  Published by:  DelveInsight
DelveInsights Hodgkins lymphoma (HL) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Hodgkins lymphoma (HL) for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and...

$ 4,950.00

Read More

Non-Hodgkin's Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023

01 Aug 2016  |  Published by:  DelveInsight
Note*: This report requires 7-10 business days to complete.DelveInsights Non-Hodgkins Lymphoma (NHL) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Non-Hodgkins Lymphoma (NHL) for the seven major ma...

$ 4,950.00

Read More

Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2016

20 Jul 2016  |  Published by:  Global Markets Direct
SummaryAnaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2016, provides an overview of the Anaplastic Large Cell Lymphoma (ALCL) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anaplastic Large Cell Lymphoma (ALCL), complete with ...

$ 2,000.00

Read More

Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016

29 Jun 2016  |  Published by:  GlobalData
SummaryGlobalData's clinical trial report, Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016 provides an overview of Anaplastic Large Cell Lymphoma (ALCL) clinical trials scenario. This report provides top line data relating to the clinical trials on Anaplastic Large Cell...

$ 2,500.00

Read More

AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016

29 Jun 2016  |  Published by:  GlobalData
SummaryGlobalData's clinical trial report, AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016 provides an overview of AIDS - Related Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on AIDS - Related Lymphoma. Report includes an overv...

$ 2,500.00

Read More

B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

29 Jun 2016  |  Published by:  GlobalData
SummaryGlobalData's clinical trial report, “B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell Non-Hodgkin Lymphoma. Report i...

$ 2,500.00

Read More

Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016

29 Jun 2016  |  Published by:  GlobalData
SummaryGlobalData's clinical trial report, Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016 provides an overview of Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy clinical trials scenario. This report provides to...

$ 2,500.00

Read More

Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H1 2016

28 Jun 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Directs, Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulator Bcl-X or Protein Phosphatase 1 Regulatory Subunit 52 or B-cell Lymphoma Extra Large) - Pipeline Review, H1 2016, provides in depth analysis on Bcl-2-Like Protein 1 (Bcl-xl or Bcl2-L-1 or Apoptosis Regulato...

$ 3,500.00

Read More
Total 117 records.